GOOD TRADERS FORUM

[powerbattles]

$BDPT DOING A GLOBAL DRUG SPIN-OFF!! DD part 3..

One of the most appealing aspects of this company, since its inception in 2013, is its track record of avoiding reverse stock splits (r/s). Considering that this is a biotech stock operating in the early stages of development, it is common for such companies to rely on share dilution for working capital to sustain their operations. Many triple-zero stocks dilute hundreds of millions of shares on a weekly or even daily basis. However, this company has managed to maintain a relatively low outstanding share count of only 422 million over a span of ten years, which is exceptionally rare. This demonstrated restraint in share dilution speaks volumes about the company's trustworthiness and its commitment to its shareholders.
$BDPT the upcoming IPO of a new company focusing on Myopia and Presbyopia drug treatment for both humans and animals introduces a patented treatment option applicable to veterinary and human use. Pending spin-off division, named "LIVE STOCK IMPACT," will establish a prominent position in the global drug market, serving the needs of both humans and animals.

Bioadaptives launched a new Division, Livestock Impact, with its own website and marketing program
https://www.livestockimpact.com/

"The new company will continue to develop and market natural supplements for performance animals and pets, but will expand its activities globally to include botanical drugs for both veterinary and human use."

The Flying C Bar Ranch (FCBR) Therapy Division has entered into an exclusive distribution agreement with LiveStock Impact Division for the marketing of its equine and canine products.

Flying C Bar Ranch is “A One Stop Facility for All Your Equine Needs”. Ranch owners, Bruce and Denise Colclasure provide a full service cutting horse operation consisting of training, breaking and starting colts, lessons, cutting horses, barrel and roping horses for sale both prospects and finished horses, sale fitting, in-house farrier and blacksmith shop, rehabilitation and therapy center, group and individual clinics.
Flying C Bar Ranch has an energetic and highly specialized team full of energy, with expertise in making your equine goals and dreams a reality.
Flying C Bar Ranch is located in Bristow, Oklahoma between Tulsa and Oklahoma City right off Interstate 44.

https://flyingcbar.myshopify.com/
https://www.facebook.com/flyingcbarranch1/

Flying C Bar Ranch Performance Horses

In April 2023, Dr. Yaguang Liu of LY Research and Dr. David Allen joined the Company’s Board of Directors. Dr Liu is a renowned researcher and scientist in botanical drugs development with 32 patents under his name. Dr. David Allen, CEO of World Wellness, is a well-known developer and marketer of nutraceutical products, as well as being the co-founder and President of the American Botanical Drug Association.

World Wellness and $BDPT have entered into a non-exclusive marketing agreement for a comprehensive weight management system. This system includes the innovative Fit Your Outfit (FYO) App, which utilizes AI to scientifically measure body composition with a single photo taken from a smartphone. Users can now accurately measure their own body fat percentage at home, with results as precise as those obtained through methods used by medical professionals.

(FYO) AI innovation is covered by International US and EU granted patents. Was developed by two of the top body composition experts in the world and will be marketed globally.

Exploiting our invention covered by granted EU and US patents and exploiting extensively well-trained artificial intelligence to extract human profiles from any background, the proprietary patented exclusive pixel sizing and counting method yields fully automated silhouettes topped with real dimensions in metric or imperial units. Information is offered with a variety of solutions, such as Lateral Silhouette, Side by Side profile overlapping and comparisons, Total Body or Regional Elliptical Boundaries, Body Surface, Roundness Index, and best-describing fat storage Diameters of body sections at any level.
An unmatched range of solutions, customized and inclusive of accurate total fat or abdominal body fat estimates.

https://www.pixelcando.com/home

Feb. 03, 2022 they entered into a definitive agreement with inventor Thomas J. Mohr acquired his U.S. Patent 9,783,432B, with a laboratory to develop consumer products that will be marketed by BioAdaptives and Forms Subsidiary, MORO2, Inc., to Create New Products.

(Patent # US 9,622,970 B2 ) for Eye Health due to Myopia and Presbyopia is valued at US$570,000,000 by Grant Thornton.” (Patent # us 8,114,444 B2 ) for glucose management. The patent has a valuation of US$210/m as valued by Grant Thornton Accounting Firm.

Grant Thornton Accounting Firm is ranked top 6th worldwide, rankings based on the revenue of USD 7.2 billion.

The International Accounting Bulletin (IAB) has published its 2023 World Survey and we are pleased to share that Grant Thornton is ranked 6th in the global rankings based on revenue and headcount. Globally, we have recorded a revenue of USD 7.2 billion (up by 13.7% from prior year) and a headcount of 68,000 (up by 9.6% from prior year).

FROM THE 10-Q - 08/2022

The Company entered into a marketing agreement for an FDA-cleared Class II medical device, the Lung Flute™. The Company is also exploring agreements with other medical device manufacturers; the owners of intellectual property relating to medical devices and processes; and marketing companies associated with these manufacturers and owners.

The Lung Flute™ is a FDA-cleared Class II medical device that has been cleared by the FDA for both diagnostic and therapeutic use in the U.S. and has received the CE mark clearance for use in the European Union1. It facilitates effective airway clearance by generating and delivering a specific low-frequency sound that vibrates the airways and lung secretions, causing lung secretions to thin and become more mobile2. It is used to help clear respiratory tract secretions in patients with chronic obstructive pulmonary disease (COPD) which results in an improved quality of life1

It appears that the company is poised for the next phase of growth. The recent high-profile recruitments at BioAdaptives since April 2023 have been incredibly exciting for the company. These recruitments include top-notch professionals who are prepared to take us to the next level, potentially even securing a listing on a larger exchange.

CEO Graduated the best Ivy League school Leagues. Graduate of Harvard Medical school and Princeton University. IVY Legue School ranked
1 - HARVARD
2 - PRINCETON
https://prepexpert.com/ivy-league-school-rankings/#:~:text=Ivy%20League%20Schools%3A%20Ranked%201%201.%20Harvard%20Harvard,7%207.%20Dartmouth%20...%208%208.%20Cornell%20


CEO Dr. Edward E. Jacobs
Patents by Inventor Edward E. Jacobs, Jr.
https://patents.justia.com/inventor/edward-e-jacobs-jr
https://podcasts.apple.com/be/podcast/natural-green-living/id1523571157?l=nl

Dr. Edward E. Jacobs, Jr., a graduate of Princeton University and Harvard Medical school, is a biotechnology consultant with over 25 years’ experience in biopharmaceutical and medical device development, as well as, 35 years of teaching and direct patient care. Dr. Jacobs has participated in drug development process from discovery through animal and human studies, including regulatory support for FDA and international regulatory affairs, strategic planning and investor relations.

Dr. Jacobs has extensive clinical operations experience, having executed more than 15 human trials in the US, Europe, Eastern Europe, and the Republic of South Africa. He has also served as a medical monitor and liaison for clinical investigators involved with international trials with responsibility for regulatory compliance.
After completing surgical training at Harvard and research positions at the National Heart, Lung and Blood Institute, Bethesda, Maryland, and at Saint Thomas’ Hospital Medical School, London, Dr. Jacobs was a member of the Harvard Medical School staff, combining teaching with clinical practice and research. He has also served on the Scientific Advisory Board of the Armenise-Harvard Foundation and the Publications Committee for the New England Journal of Medicine Scientifically, Dr. Jacobs has made original observations in the field of tissue oxygenation therapy and water modification. His current focus is on natural products for animal and human use, anti-ageing strategy, and primitive cell biology.
He is an author of more than 40 scientific publications and is the holder of four patents.


Robert Ellis brings more than forty years of business management experience to the Company. He has worked extensively in senior positions across a variety of industry disciplines, including aerospace, electronics, communications, and international marketing. Mr. Ellis has been an executive officer in private and public companies, both major entities, start-ups, and emerging entities. He has an Accounting Degree from the University of Illinois, and is a CPA.

DD part # 1
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172123754
DD part # 2
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172140082

If you compare the notes with other stocks traded on OCT, they are very minimal. Referring to the table below, convertible notes as of March 31, 2023, and December 31, 2022, and nonconvertible notes issued in fiscal year 2023.


Best share structure
Reporting Status Audited Financials
U.S. Reporting: SEC Reporting
Authorized Shares 1,250,000,000 - 05/31/2023
Outstanding Shares - 422,991,798 - 05/31/2023
Restricted 15,491,267- 05/31/2023
Unrestricted 407,500,531 - 05/31/2023
Held at DTC 404,629,298 - 05/31/2023

Recap from last week, great posts
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172158427
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172159777
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172161312
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172163784
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172158427
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172159225
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172160620
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172159641
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172159600